Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Management change at Handelsbanken

Rolf Marquardt, Chief Financial Officer at Handelsbanken, will leave his position on 31 March 2020. He will continue as CFO and will remain a member of executive management until that date, after which he will continue to be employed by Handelsbanken. The recruitment process for his successor will be initiated immediately.  For further information, please contact:Carina Åkerström, President and Group Chief Executive,tel: +46 8 22 92 20 Maria Nordin Wessman, Acting Chief Communications Officer,tel: +46 8 701 16 73 Mats Olsson, Press Officer,tel: +46 8 701 35 47, +46 70

Optimized business model and reduced risk level result in revaluations in Q3 2019

Following a review of the company’s operations, SSM Holding AB (publ) today resolved to optimize the company’s business model. The decision has led to the revaluation of certain projects and joint venture assets. The revaluations will not affect the company’s cash flow but are expected to have a -312.7 MSEK impact on the results for Q3 2019.Following the review of SSM’s operations that was carried out during the third quarter 2019, the company’s Board of Directors today resolved to optimize SSM’s business model to adapt to current market conditions. As a result, certain projects and joint

SynAct receives approval from the Swedish Medical Product Agency and the Swedish Ethical Review Authority regarding the clinical Phase IIa study with AP1189

SynAct ("SynAct") announces that the company has received approval from the Swedish Medical Product Agency and the Swedish Ethical Review Authority to conduct the company’s Phase IIa study with the drug candidate AP1189. SynAct also announces that an application for clinical trial has been filed to the Norwegian Medicines Agency and Norwegian National Committee for Medical and Health Research Ethics.The Study is currently ongoing on clinical sites in Denmark following approval by the Danish Medicines Agency in June 2019. With the approval by the Swedish Medical Product Agency, patients can

Third Quarter 2019 Financials

Highlights · 3Q19 revenue was USD 5 353 thousand, mainly driven by Conan Exiles and Mutant Year Zero: Road to Eden. 3Q18 revenue was USD 7 534 thousand driven by the very successful Conan Exiles Japan launch and a strong effect of the Conan Exiles full game launch in 2Q18 · Despite 3Q19 being a quarter without new game releases the EBITDA was USD 2 148 thousand, and the EBITDA margin was 40% for the quarter and 49% for the last 12 months. 3Q18 EBITDA was USD 4 642 thousand, again mainly driven by the launch effect of Conan Exiles · On 31 July, Funcom made its first

Aker Solutions ASA: Mandatory Notification of Trade

November 11, 2019 - Aker Solutions ASA today bought 91,930 own shares at an average price of NOK 22.68 per shareThe shares were acquired on the Oslo Stock Exchange as part of the company's share purchase program for employees. This gives Aker Solutions a new holding of 1,193,287 own shares. For more information about the share purchase program, please see the release published November 1, 2019 . ENDS Media Contact:Ivar Simensen, mob: +47 464 02 317, email: ivar.

Notice by Starbreeze of presentation of final reconstruction plan

STOCKHOLM (November 11, 2019) – A reconstruction plan and petition for composition negotiations were submitted today to the Stockholm District Court as part of the reconstruction process for Starbreeze AB (publ) and related subsidiaries. In this plan, the Administrator presents information including the proposed agreements presented to creditors of Starbreeze for the settlement of its debts.  Starbreeze has been in reconstruction since 3 December 2018. The company’s total debt amounted to SEK 395,7 million at November 6, 2019. Aimed at reaching agreements for the settlement of the

FSN CAPITAL SHAREHOLDERS AND CERTAIN SENIOR EXECUTIVES OF BYGGHEMMA ANNOUNCE THEIR INTENTION TO OFFER SHARES IN BYGGHEMMA GROUP FIRST AB TO EQT PUBLIC VALUE FUND AND OTHER INSTITUTIONAL INVESTORS

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Press release Stockholm, 11 November 2019, 17:30 CET FSN CAPITAL SHAREHOLDERS AND CERTAIN SENIOR EXECUTIVES OF BYGGHEMMA ANNOUNCE THEIR INTENTION TO OFFER SHARES IN BYGGHEMMA GROUP FIRST AB (PUBL) TO EQT PUBLIC VALUE FUND AND OTHER INSTITUTIONAL INVESTORS EQT Public Value Fund FCP-RAIF  (“EQT Public Value Fund”)[1]  has declared its interest to acquire

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 11.11.2019

Fiskars Corporation  NOTIFICATION 11.11.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 11.11.2019 Date 11.11.2019Exchange transaction BuyShare class FSKRSAmount       1000Average price/share 11.9600 EUR  Highest price/share 11.9800 EUR Lowest price/share 11.9000 EUR Total price  11,960.00 EUR  The shares held by Fiskars Corporation on 11.11.2019: FSKRS 377,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

Nustay issues comprehensive market update on recent performance

Nustay A/S (“Nustay”) has today issued a comprehensive market update on the Company’s progress against its key performance indicators (KPIs) since its IPO early 2019. Today’s update does not change or affect the company’s current capitalization needs, as communicated to the market on October 11th, 2019. Today’s update seeks to provide the market with a deeper understanding of the Company’s operations and most recent actions, and through this, highlight the potential for further growth. The Company has announced that handled revenue in Q3 saw a year-on-year increase of 709% - from 3.4 MDKK in

Össur hf: Transactions in relation to share buyback program

Announcement no. 69/2019 11 November 2019On 10 September 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 53/2019. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 31 December 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The total consideration for shares purchased under

Elkem ASA - Disclosure of voting rights for the chairman of the board of directors, Michael Koenig

Oslo, 11 November 2019 As of close of business on 11 November 2019, the chairman of the board of directors of Elkem ASA, Michael Koenig, has received power of attorneys to represent and vote for 338.526.123 shares, corresponding to 58,24% of the share capital, at Elkem ASA's extraordinary general meeting to be held on 15 November 2019. In addition, Mr. Koenig and his close associates holds 68,965 shares in Elkem ASA, representing 0.119 % of the share capital. In total, Mr. Mr. Koenig will represent and vote for 338.595.088 shares, representing 58,36 % of the share capital of Elkem ASA

Tokmanni already has 23 solar power plants in use – and this number will increase – “We also want to make smart choices when it comes to energy”

Tokmanni     Press release     11 October 2019 at 5:30 p.m.[Tokmannis solar power plant Administration and Logistics Centre Mntsl]One of the largest solar power plants in Finland is located on the roof of the Tokmanni's administrative and logistics centre in Mäntsälä. Photo: Tokmanni  The number of solar power plants on the roofs of Tokmanni stores has grown significantly this year. Renewable energy is now already being produced by 23 separate solar power plants, with a total of about 14,600 solar panels, installed on the roofs of Tokmanni stores across the country and the administrative

#19-1127 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

YIT and the City of Järvenpää to sign a contract concerning the Perhelä area development

YIT Corporation Press release, November 11, 2019 at 5:00 p.m.Järvenpää City Council approved the Perhelä set of contracts. The zoning process for the project will start in early 2020. The joint planning between YIT and the City of Järvenpää concerning the Perhelä project has entered the contract phase. Järvenpää City Council approved the proposal for the set of contracts concerning the Perhelä block today on November 11. Among the matters agreed upon in the implementation contract are the basic principles of construction, changes in the local detailed plan and the schedule. The

Using mountains for long-term energy storage

The storage of energy for long periods of time is subject to special challenges. An IIASA researcher proposes using a combination of Mountain Gravity Energy Storage (MGES) and hydropower as a solution for this issue.Batteries are rapidly becoming less expensive and might soon offer a cheap short-term solution to store energy for daily energy needs. However, the long-term storage capabilities of batteries, for example, in a yearly cycle, will not be economically viable. Although pumped-hydro storage (PHS) technologies are an economically feasible choice for long-term energy storage with

NetEnt scores hattrick at Southern European Gaming (SEG) awards

NetEnt was crowned Best Online Casino Provider, Best Live Casino Provider, and Best Support for Responsible Gambling at the prestigious SEG ceremony in Milan on Friday. Established to celebrate the industry’s major achievements of 2019, the Southern Gaming Awards welcomed representatives at the Radisson Blu Hotel Milan as part of the European Gaming Congress which took place in the Italian capital last week.  NetEnt’s accolades are a testament to the company’s marked success in the last 12 months with groundbreaking releases that continue to raise the bar of Live Casino and

Akelius’ preference share is de-listed 2019‑12‑13

Nasdaq Stockholm has approved the application for de‑listing of Akelius’ preference share from Nasdaq First North Growth Market. The last day of trading in the preference shares is 2019‑12‑13.Record date is 2019-12-17.Settlement date is expected to be 2019-12-20. The redemption is automatic,the shareholders do not need to take any measures. Stockholm, 2019-11-11 Pål Ahlsén CEO +46 768 07 97 02 pal.ahlsen@akelius.se Akelius Residential Property AB’s preference shares and D-shares are listed on Nasdaq First North Growth Market Stockholm. Avanza Bank is the

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2019

Strong sales growth during October; Zinzino group revenue increased with a total of 52% compared with the previous year.The revenue in October for Zinzino's sales markets increased by 55% to MSEK 84.1 (54.1) due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 3% and amounted to MSEK 4.2 (4.1). Overall the Group increased revenues by 52% to MSEK 88.3 (58.2) compared with the previous year.Accumulated revenue for January – October 2019 increased by 30% MSEK 622.62 (479.1). Revenues distributed as follows: +--------------------+------+------+------

Interim report April - September 2019

CEO’s commentsFinanciallyThe investments EQL Pharma made in its product portfolio in recent years continue to provide good returns. For the second quarter in a row, sales increased by more than 30 percent compared to the same period last year. Quarterly sales are also the company's best since the company was founded. Through efficient working capital financing, cash liquidity is good despite large continued investments in the product portfolio. MarketDuring the quarter, EQL Pharma got its first hospital product approved. The product is approved for sale in Sweden, Denmark, Norway and

SBB redeems outstanding SEK perpetual capital securities

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

SEMAFO Updates on Boungou

Montreal, Quebec, November 11, 2019 /CNW/ – SEMAFO Inc. (TSX, OMX: SMF) (“SEMAFO”) reports that over the weekend we began transportation of people by helicopter from the Boungou Mine site. Benoit Desormeaux, President and CEO of SEMAFO states: “Many of the people on-site need to be home with their families and to recover from last week’s incident. Myself and most of our senior management team are in-country ensuring all those affected are getting the support they require. Our priority continues to be their safety, security and well being.” A total of 241 of our employees, contractors

Scandic again finalist in European Diversity Awards

Scandic has once again been shortlisted in the European Diversity Awards category “Diversity Team of the Year” thanks to the company’s world-leading initiatives within accessibility and employee training. The awards ceremony will be held at a gala in London on November 14, 2019.Scandic’s position as finalist follows from the new online accessibility course that the company launched in May 2019. The course offers a full digital experience including concrete instructional films, tips and advice on how Scandic can provide the best possible service for guests with accessibility needs. The

Positive safety review of Remygen[®] gives clearance to start next part of Phase I/II trial in type 1 diabetes patients

The initial safety and dose escalation part of the Phase I/II trial with Remygen[®] in type 1 diabetes patients, ReGenerate-1, has been completed. The safety data from the six patients included in this first part of the trial has been evaluated by an independent Data Safety Monitoring Board (DSMB) who recommends that the main study can start. Metabolic results from the now completed safety and dose escalation part are being compiled and will be presented later this year."We already have the first participants ready to enter the next part of the trial," says Per-Ola Carlsson, Professor at

There are no items matching the current filter
There are no more items matching the current filter
Back to top